EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment

The incidence of prostate cancer increases with age and because of its high prevalence this disease has become a major public health concern. Despite advances in our understanding of the biological mechanisms responsible for the development of this cancer, the transition to the hormone refractory st...

Full description

Bibliographic Details
Main Authors: Gerard Milano, Alexandre Bozec, Jean-Marc Ferrero, Jean Louis Fischel, Olivier Guérin
Format: Article
Language:English
Published: MDPI AG 2010-07-01
Series:Pharmaceuticals
Subjects:
chemotherapy
targeted therapy
EGFR
kinase inhibitors
prostate cancer
hormone-resistant prostate cancer
geriatric oncology
Online Access:http://www.mdpi.com/1424-8247/3/7/2238/

Internet

http://www.mdpi.com/1424-8247/3/7/2238/

Similar Items